VEGFA and tuberculosis: Similar results were observed for VEGF-A, with the combination of Xpro-1595 and anti-TB drugs significantly reducing VEGF-A levels compared to anti-TB drugs alone, effectively lowering angiogenic factor levels to those of the control group (Fig. 6).